Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0JYFQF)
| ADC Name |
ZPC-21
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
ZPC-21; IM-1021
Click to Show/Hide
|
|||||
| Organization |
Zentalis Pharmaceuticals (Originator) (No Rights);Immunome
|
|||||
| Drug Status |
Phase 1
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Anti-ROR1 mAb
|
Antibody Info | ||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
HC74
|
Payload Info | ||||
| Payload Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
A cleavable linker
|
Linker Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC